STREMYR
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Jan 2026)
What this means for you
This application is over — abandoned 26 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98180040
- Mark type
- Stylized text
- Filed
- 14 Sept 2023
- Published for opposition
- 30 Apr 2024
- Abandoned
- 26 Jan 2026
- Attorney of record
- Michelle E. Tochtrop
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of psoriasis, psoriatic arthritis, Crohn's disease, or ulcerative colitis
Owner
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
Prosecution history
- 26 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2025 — SOU EXTENSION 2 GRANTED
- 23 Jun 2025 — SOU EXTENSION 2 FILED
- 23 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2024 — SOU EXTENSION 1 GRANTED
- 09 Dec 2024 — SOU EXTENSION 1 FILED
- 09 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED